| Beaver Brothers Dentistry, Pllc | |
|
103 Industrial Rd Checotah OK 74426 | |
| (539) 226-0018 | |
| Not Available |
| Full Name | Beaver Brothers Dentistry, Pllc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 103 Industrial Rd, Checotah, Oklahoma |
| Authorized Official Name and Position | Aaron Beaver (CO-OWNER) |
| Authorized Official Contact | 4056644473 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Beaver Brothers Dentistry, Pllc 115245 S 4189 Rd Checotah OK 74426-4474 Ph: () - | Beaver Brothers Dentistry, Pllc 103 Industrial Rd Checotah OK 74426 Ph: (539) 226-0018 |
| NPI Number | 1346810389 |
|---|---|
| Provider Enumeration Date | 07/01/2021 |
| Last Update Date | 07/01/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346810389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
Cowen Healthcare Royalty Partners ("Cowen Royalty") today announced that it has established a Strategic Advisory Board to extend the Firm's functional knowledge and geographic base within the healthcare industry.
A team of social scientists and medical and nursing researchers in the United States and the United Kingdom has pinpointed how a programme, which ran in more than 100 hospital intensive care units in Michigan, dramatically reduced the rates of potentially deadly central line bloodstream infections to become one of the world's most successful patient safety programmes.
Malaria was already widespread on Sardinia by the Roman period, long before the Middle Ages, as indicated by research at the Institute of Evolutionary Medicine of the University of Zurich with the help of a Roman who died 2,000 years ago.
Even modest increases in blood levels of triglycerides, as well as a type of high cholesterol known as type III hyperlipidemia, are strongly associated with coronary artery disease in people with a family history of the disease, according to a new study in the April 5, 2005, issue of the Journal of the American College of Cardiology.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD) at a recommended dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 mg every eight weeks.
› Verified 5 days ago
Affordable Dentures & Implants - Oklahoma, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 N W 9th St, Checotah, OK 74426 Phone: 918-473-3700 |